Cepheid Asks Federal Court to Rule Two Roche PCR Patents Invalid | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid is asking a federal court to declare two patents held by Roche invalid.

In a lawsuit filed last week in the US District Court for the Northern District of California, Cepheid asked the court also to find that it does not infringe US Patent Nos. 5,804,375 and 6,127,155 held by Roche.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.